|
2026
|
Invention
|
Methods of synthesizing 4-valyloxybutyric acid.
The present disclosure is directed synthetic met... |
|
2025
|
Invention
|
Crystalline 4-((l-valil)oxy)butanoic acid salts. LLLLL-valil)oxy)butanoic acid salts are disclosed. |
|
|
Invention
|
Crystalline 4-((l-valyl)oxy)butanoic acid salts.
Crystalline 4-((L-valyl)oxy)butanoic acid salts... |
|
|
Invention
|
Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative.
Pha... |
|
|
Invention
|
Pharmaceutical compositions and oral dosage forms of ketamine derivatives.
Pharmaceutical compos... |
|
|
Invention
|
Modified release compositions of a gamma-hydroxybutyric acid derivative.
Pharmaceutical granulat... |
|
|
Invention
|
Controlled release granulations of water-soluble active pharmaceutical ingredients.
Pharmaceutic... |
|
2024
|
Invention
|
Ketamine derivatives and compositions thereof.
Ketamine derivatives and pharmaceutical compositi... |
|
|
Invention
|
Methods of synthesizing 4-valyloxybutyric acid. The present disclosure is directed synthetic meth... |
|
|
Invention
|
Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative. Phar... |
|
|
Invention
|
Modified release compositions of a gamma-hydroxybutyric acid derivative. Pharmaceutical granulati... |
|
2023
|
Invention
|
Crystalline 4-((l-valyl)oxy)butanoic acid |
|
|
Invention
|
Crystalline 4-((l-valyl)oxy)butanoic acid.
Crystalline 4-((L-valyl)oxy)butanoic acid, methods of... |
|
|
Invention
|
Compounds as nuclear transport modulators and uses thereof. Nuclear transport modulators are disc... |
|
|
Invention
|
Pharmaceutical compositions and oral dosage forms of ketamine derivatives. Pharmaceutical composi... |
|
2022
|
Invention
|
Ketamine derivatives and compositions thereof. Ketamine derivatives and pharmaceutical compositio... |
|
|
Invention
|
Compounds as neuronal histamine receptor-3 antagonists and uses thereof. The present invention re... |
|
|
Invention
|
Bicyclic heteroaryl derivatives and preparation and uses thereof. The present invention relates c... |
|
|
Invention
|
Pharmaceutical granulations of water-soluble active pharmaceutical ingredients.
Granulations wit... |
|
|
Invention
|
Pharmacokinetics of combined release formulations of a γ-hydroxybutyric acid derivative. Pharmace... |
|
|
Invention
|
Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative. LLLγ... |
|
|
Invention
|
Controlled release granulations of water-soluble active pharmaceutical ingredients. Pharmaceutica... |
|
2021
|
Invention
|
Compounds as neurokinin-1 receptor antagonists and uses thereof. The present invention relates co... |
|
|
Invention
|
Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative. Pharm... |
|
|
Invention
|
Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative. LLL-v... |
|
|
Invention
|
Pharmaceutical granulations of water-soluble active pharmaceutical ingredients. Granulations with... |
|
|
Invention
|
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof.
Provided are prodrugs of g... |
|
2020
|
Invention
|
Reactive oxygen species scavengers and use for treating diseases. A compound of Formula (I), phar... |
|
|
Invention
|
Preparation and uses of reactive oxygen species scavenger derivatives. Compounds of Formula (I)a ... |
|
|
Invention
|
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof. Provided are prodrugs of ga... |
|
2019
|
G/S
|
Pharmaceuticals for treating and managing neurological disorders Pharmaceutical research and deve... |
